BRAINSTORM CELL THERAPEUTICS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 43.80 thousand shares as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2026-03-31
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 43.80K shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 69.18K shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 80.08K shares; Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number as first filed 1.20M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.15M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number as first filed |
|---|---|---|
| 2025-12-31 | 43.80K shares 10-K · filed 2026-03-31 | |
| 2024-12-31 | 69.18K shares 10-K · filed 2026-03-31 | |
| 2023-12-31 | 80.08K shares 10-K · filed 2025-03-31 | 1.20M shares 10-K · filed 2024-04-01 |
| 2022-12-31 | 1.15M shares 10-K · filed 2024-04-01 | |
| 2021-12-31 | 995.36K shares 10-K · filed 2023-03-30 | |
| 2020-12-31 | 998.53K shares 10-K · filed 2022-03-28 | |
| 2019-12-31 | 823.01K shares 10-K · filed 2021-02-04 | |
| 2018-12-31 | 840.58K shares 10-K · filed 2020-02-18 | |
| 2017-12-31 | 811.82K shares 10-K · filed 2019-04-01 | |
| 2017-03-31 | 6.32M shares 10-Q · filed 2017-05-15 | |
| 2016-12-31 | 839.51K shares 10-K · filed 2018-03-08 | |
| 2015-12-31 | 611.76K shares 10-K · filed 2017-03-29 | |
| 2014-12-31 | 331.50K shares 10-K · filed 2016-03-09 | |
| 2013-12-31 | 335.80K shares 10-K · filed 2015-03-26 | |
| 2012-12-31 | 3.85M shares 10-K · filed 2013-03-14 | |
| 2012-06-30 | 46.55M shares 10-Q/A · filed 2012-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |